Yokogawa’s Acquisition of Insilico Biotechnology

Heuking Kühn Lüer Wojtek advised Insilico Biotechnology AG shareholders on the deal. Bird & Bird advised Yokogawa Electric Corporation.

The shareholders of Insilico Biotechnology AG announced the sale of all their shares to Japanese Yokogawa Electric Corporation and accompanied the transaction.

Established in Stuttgart in 2001, Insilico Biotechnology AG has offices in Singapore and Boston (USA). Insilico develops and markets digital solutions for biotechnological process development, biotechnological production, and purification. The range of products supported by the digital solutions includes biologics, biosimilars, vaccines, peptides, small molecules, clean meat, and cells for gene and cell therapy. With its “Digital Twin Factory” software platform Insilico offers an innovative technology for the prediction and simulation of metabolism processes as well as the construction of metabolism models of various kinds of cellular organisms.

Founded in Tokyo in 1915, Yokogawa Electric Corporation provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations.

The Heuking team included Dr. Peter Ladwig (Picture),  Dr. Alexander Schott (both Lead, Corporate/M&A), Anika Daschmann (Corporate/M&A), Dr. Markus Klinger (IP/IT), Fabian G. Gaffron and Dr. Sarah Slavik-Schulz (both Tax).

Yokogawa Electric Corporation was advised by the following Bird & Bird lawyers: partner Stephan Kübler, LL.M., associate Daniel Gloor, counsel Michael Gaßner, all corporate/M&A, partner Dr. René Voigtländer and associate Nina Rücker, both regulatory & administrative, partner Dr. Henriette Picot and associate Goekhan Kosak, both tech & comms/commercial, partner Dr. Ralph Panzer and associate Laura Schildberg, both employment, partner Dr. Christopher Maierhöfer and associate Dominik Igel, both patents, all Munich, partner Dr. Stephan Waldheim, EU & competition, Düsseldorf.

Involved fees earner: Michael Gaßner – Bird & Bird; Daniel Gloor – Bird & Bird; Dominik Igel – Bird & Bird; Goekhan Kosak – Bird & Bird; Stephan Kübler – Bird & Bird; Christopher Maierhöfer – Bird & Bird; Ralph Panzer – Bird & Bird; Henriette Picot – Bird & Bird; Nina Rücker – Bird & Bird; Laura Schildberg – Bird & Bird; René Voigtländer – Bird & Bird; Stephan Waldheim – Bird & Bird; Fabian Gaffron – Heuking Kühn Lüer Wojtek; Markus Klinger – Heuking Kühn Lüer Wojtek; Peter Ladwig – Heuking Kühn Lüer Wojtek; Alexander Schott – Heuking Kühn Lüer Wojtek; Sarah Slavik-Schulz – Heuking Kühn Lüer Wojtek;

Law Firms: Bird & Bird; Heuking Kühn Lüer Wojtek;

Clients: Insilico Biotechnology AG; Yokogawa Electric Corporation;

Federica Tiefenthaler

Author: Federica Tiefenthaler